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ABSTRACT 
Osteoarthritis (OA) is characterized by inflammation of the knee joint, which is caused by accumulation of cyto-
kines and C-reactive protein (CRP) in the extracellular matrix as an early immune response to infection. The 
articular cartilage destruction is discernible by elevated tumour necrosis factor- (TNF-. In this study, blood 
samples of knee osteoarthritis patients were analyzed for biochemical and physiological parameters based on the 
lipid profile, uric acid, total leukocyte count (TLC), hemoglobin percentage (Hb%) and absolute lymphocyte 
count (ALC). Furthermore, immunological parameters including TNF-, interleukin-6 (IL-6) and CRP were 
analyzed. The presence of antibodies against hydroxyl radical modified collagen-II (•OH-collagen-II) was also 
investigated in arthritis patients using direct binding ELISA. The uric acid and lipid profiles changed extensive-
ly. Specifically, increased uric acid levels were associated with OA in both genders, as were enhanced immuno-
logical parameters. The TNF- level also increased in both genders suffering from OA. Finally, auto-antibodies 
against OH-collagen II antigen were found in the sera of arthritis patients. These results indicated that immuno-
logical parameters are better predictors or indexes for diagnosis of OA than biochemical parameters. 
 
Keywords: Osteoarthritis, collagen-II, biochemical and immunological parameters 
 
 
 
INTRODUCTION 
Osteoarthritis (OA) is a common, age-
related, heterogeneous group of disorders 
characterized pathologically by focal areas of 
loss of cartilage in synovial joints that is as-
sociated with varying degrees of osteophytic 
formation, subchondral bone change which 
grip the whole joint, i.e. articular cartilage, 
subchondral bone alterations and joint-lining 
synovial membrane. Correspondingly, de-
velopment of osteoarthritis involves elabo-
rate interactions of cartilaginous tissue me-
tabolism and maintenance, osteogenesis, 
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mineralization and inflammation of the syn-
ovial membrane. Identification of the molec-
ular pathways and individual factors in-
volved in its etiology and understanding of 
mechanisms of their action and interaction 
are prerequisite to the development of accu-
rate diagnostic and prognostic tools and 
providing OA patient’s effective treatment. 
There has been great progress in understand-
ing molecular mechanisms of OA appear-
ance and progression, including identifica-
tion of a network of biochemical factors that 
are important to normal functioning of the 
joints and changes leading to osteoarthritis 
(Livshits et al., 2010). Despite these advanc-
es in knowledge regarding the biochemistry 
of OA, valid breakthroughs in this area are 
still needed. 
There are also distortions in the synovial 
membrane and para-articular structures. Evi-
dence has shown that biochemical and im-
munological parameters are important fac-
tors contributing to the development of OA. 
For example, estrogen deficiency has been 
reported to increase TNF- production by 
monocyte-enriched peripheral blood mono-
nuclear cells, as well as unfractionated hu-
man and murine bone marrow cells. Further, 
studies in humans have shown that adherent 
mononuclear blood cells contain CD3+ and 
CD56+ lymphocytes, a TNF- producing 
subset of adherent T cells, and that the levels 
of these T cells decrease in response to es-
trogen treatment and are inversely correlated 
with bone density (Dantas and Sandberg, 
2005). Non-enzymatic glycation reaction has 
also been reported to play a role in the initia-
tion and progression of arthritis (Saudek and 
Kay, 2003). Non-enzymatic glycation of pro-
teins, nucleic acids and lipids results in the 
formation of advanced glycation end prod-
ucts (AGEs) (Ahmad et al., 2013a, b; Akhter 
et al., 2013a, b; Rahim et al., 2014; Shahab 
et al., 2014; Ashraf et al., 2015a-c), as well 
as proteins such as collagen. AGEs cause 
pathologic stiffening of cartilage and extra-
cellular matrix and accumulate with age. 
Pentosidine, an AGE, is present in serum, 
synovial fluid, and articular cartilage from 
patients with osteoarthritis (Mustafa et al., 
2012; Ashraf et al., 2014, 2015b). AGE 
modification of normal articular cartilage 
increases stiffness, facilitates chondrocyte-
mediated proteoglycan degradation, reduces 
susceptibility to matrix metalloproteinase-
mediated degradation, and decreases proteo-
glycan synthesis by chondrocytes. These ob-
servations parallel findings for osteoarthritic 
cartilage, suggesting that AGE modification 
could contribute to the pathogenesis of oste-
oarthritis (Saudek and Kay, 2003). 
OA is one of the most common joint dis-
orders, and is more prevalent in females than 
in males. OA is primarily a non-inflam-
matory disorder of movable joints character-
ized by an imbalance between the synthesis 
and degradation of articular cartilage, lead-
ing to classic pathological changes of wear-
ing away and destruction of cartilage (Mish-
ra et al., 2013). Many factors affect osteoar-
thritis, including age, gender, genetic factors, 
estrogen in women, exercise and sports 
(Roman-Blas et al., 2009). The major struc-
tural protein of cartilage is type II collagen 
(Shahab et al., 2012a), which maintains and 
binds matrix molecules important for carti-
lage stability (IX and XI) (Creamer and 
Hochberg, 1997). The cartilage stabilities are 
also affected by various cytokines, including 
interleukin-1 (IL-1) and TNF- 
Bone resorbing activity of peripheral 
blood monocyte culture supernatants was 
shown to be higher in postmenopausal wom-
en than premenopausal women. Decreased 
blood estrogen levels and increased bone re-
sorbing activity in postmenopausal women 
leads to IL-1 and TNF- production from 
peripheral blood monocytes and bone mar-
row cells. IL-1 and TNF- stimulate chon-
drocytes to produce more degrading en-
zymes and other cytokines such as IL-6, IL-
8, nitric oxide and prostaglandin E2.  
The present study was conducted to iden-
tify physiological, biochemical and immuno-
logical factors playing a major role in the 
development of osteoarthritis disease in el-
derly patients. Furthermore, the presence of 
auto-antibodies was probed against native 
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and hydroxyl-modified-collagen in the sera 
of OA patients. 
 
MATERIALS AND METHODS 
Anti-human alkaline phosphatase conju-
gate, p-nitrophenyl phosphate, Tween-20, 
protein-A agarose, sodium azide, and dialy-
sis tubing were purchased from Sigma 
Chemical Company, USA. Flat bottom poly-
sorp enzyme linked immunosorbent assay 
(ELISA) modules were acquired from 
NUNC, Denmark. All other reagents/chemi-
cals were of the highest analytical grade 
available. 
The present study was carried out on 100 
human subjects aged 40–60 years, among 
which 20 were normal healthy controls and 
80 were OA patients. These patients were 
taken from the outpatient department (OPD) 
of the orthopaedic department of Hind Insti-
tute of Medical Sciences (HIMS), Barabanki, 
India. Informed consent was obtained from 
all patients enrolled in this study. Additional-
ly, the study was conducted according to the 
guidelines of the declaration of Helsinki and 
all the authors confirm that they have com-
plied with the World Medical Association 
Declaration of Helsinki regarding ethical 
conduct of research involving human sub-
jects. 
 
Collection of blood sample 
10 ml of blood sample was taken from an 
ante-cubital vein under aseptic conditions. 
2 ml blood was transferred to a citrate vial 
for erythrocyte sedimentation rate (ESR) es-
timation and 1 ml blood was transferred to 
an EDTA vial for physiological parameters 
and 7 ml blood was transferred to a plain vial 
for serum collection for immunological 
analyses. The blood sample, collected in a 
plain vial was kept for 30 minutes. Serum 
was separated from clotted blood, centri-
fuged at 3000 rpm for 5 min. Thus serum 
was kept at 56 °C for 30 min for de-comple-
mentation. 
 
Physiological parameters 
Hemoglobin (Hb) was estimated using a 
Cayman’s Hb assay kit (Schechter, 2008). 
Briefly, blood was collected in a heparin vial 
and diluted with the provided sample buffer. 
A dilution of ≥ 1:10 was required before as-
saying a sample. Next, 200 l of standard Hb 
was added to the standard wells of the plate. 
A total of 20 l of blood and 180 l of he-
moglobin detector were then added in dupli-
cate to the sample wells, after which the 
plate was covered with the plate cover and 
incubated for 15 minutes at room tempera-
ture. Finally, readings were taken at wave-
length of 580 nm.  
The Erythrocyte sedimentation rate was 
measured (to detect inflammation associated 
with conditions such as infections, and auto-
immune diseases) and evaluated by Fahraeus 
and Westergren method. In brief, 0.4 ml of 
3.8 % sodium citrate (anticoagulant) was 
taken into 2 ml sterile syringe. Now fill the 
syringe up to 2 ml volume with venous blood 
from the cubital vein. Blow out the blood 
carefully from the syringe into the bowl. 
Press the pipette at the bottom of the screw 
and rotating the screw push the blood up to 
the mark 0. Start to measure the time. Tilt 
the pipettes with blood into 45° angle using a 
stand for pipettes. After 15 minutes read a 
value of ESR, which is approximately corre-
sponding with the value read after 1 hour of 
investigation by classical method.  
 
Biochemical parameters 
Estimation of serum estrogen (Estradiol- 
17Estradiol, secreted by premenopausal 
ovary) was done according to the manufac-
turer, CAYMAN Chemical instructions kit. 
Estimation of uric acid (PAP-Uricase meth-
od) was done as per SRL diagnostic's in-
structions. Briefly, as described by Praetori-
us and Poulson, this method utilizes the en-
zyme uricase to oxidise uric acid. Pipette in-
to test tubes labelled blank (B), standard (S), 
and test (T) as follows: 
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Table 1: Biochemical parameters 
Reagent Blank 
(B) 
Standard 
(S) 
Test 
(T) 
Uric acid 
reagent 
1.0 ml 1.0 ml 1.0 ml 
Uric acid 
standard 
(conc. 
8 mg/dl) 
- 25 µl - 
Specimen - - 25 µl 
Mix and incubate for 5 minutes at 37°°C 
at room temperature. Mix and read the ab-
sorbance at 546 nm. 
 
 
Table 2: Serum cholesterol estimation 
Reagent Blank 
(B) 
Standard 
(S) 
Test 
(T) 
R2 1.0 ml 1.0 ml 1.0 ml 
Standard - 10 µl - 
Specimen - - 10 µl 
Estimation of serum cholesterol (CHOD-
PAP method) was done as per SRL diagnos-
tic's instructions. Pipette into test tubes la-
belled blank (B), standard (S), and test (T). 
Mix, incubate samples for 5 min at 20-25 °C. 
Measure the absorbance of specimen (Aspeci-
men) and standard (Astandard) against reagent 
blank. The colour is stable for 60 minutes. 
The intensity of the colour produced is di-
rectly proportional to cholesterol concentra-
tion. It is determined by measuring the in-
crease in absorbance at 500–550 nm. 
 
Cholesterol concentration was calculated 
by using the following formula: 
 
Estimation of serum triglycerides (GOP-
ESPAS method), lipo-protein, and high den-
sity lipoprotein-cholesterol (HDL-C) 
(CHOD-PAP method) was done as per SRL 
diagnostic's instructions. 
 
Table 3: Serum triglyceride estimation 
Component Colorimetric  
Reaction Mix (µL) 
Triglyceride assay buffer 46 
Triglyceride probe 2 
Triglyceride enzyme mix 2 
50 µL of reaction mixture was added into 
each well. Mixing and incubation at room 
temperature for 60 minutes was done. Ab-
sorbance was taken at 570 nm. Mean absorb-
ance blank value was subtracted from all the 
standard and sample readings. Finally stand-
ard graph was plotted to calculate triglycer-
ide. 
 
 
Table 4: Lipoprotein and HDL-C cholesterol  
estimation 
Component Total Choles-
terol Reaction 
Mix (µL) 
Free Choles-
terol Reaction 
Mix (µL) 
Cholesterol 
Assay Buffer 
44 46 
Cholesterol 
Probe 
2 2 
Enzyme Mix 2 2 
Cholesterol 
Esterase 
2 0 
Mixing of reagents for the number of as-
says was done. 50 µL of total cholesterol re-
action mixture was added into the standard 
wells, as well as into the total cholesterol 
sample wells. Furthermore, 50 µL of free 
cholesterol reaction mixture was added to 
free cholesterol sample wells, mixed and in-
cubated at 37 °C for 60 min. Absorbance 
was taken at 570 nm. Calculation was done 
by subtracting the mean absorbance value of 
the blank from all standard and sample read-
ings. Finally, standard graph was plotted to 
calculate cholesterol (LDL-C/HDL-C) con-
centration. 
 
Immunological parameters 
Determination of C-reactive protein 
(CRP): CRP estimation was done as per 
Cayman Chemical instructions. In brief, ad-
dition of 50 µL of sample diluent (contain 
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0.1 % sodium azide) was added into 96 well 
plate. After sample diluent, 50 µL of stand-
ard or sample was added to wells in dupli-
cate. Plate was covered and incubated at 
room temperature (RT) for 1 hour. Plate was 
washed three times and 100 µL of Biotinyl-
ated Antibody Reagent (contains 0.1 % sodi-
um azide) was added to wells and incubated 
at RT for 1 hour. Plate was further washed 
for three times to remove the unbound anti-
gen. 100 µL of Streptavidin HRP (horserad-
ish peroxidase) reagent was added to each 
well and plate was incubated at RT for 30 
minutes. Plate was again washed for three 
times and addition of 100 µL TMB (3,3′,5,5′-
Tetramethylbenzidine) substrate was done to 
each well and incubated in the dark for 30 
minutes. 100 µL of Stop Solution was added 
to each well and absorbance was measured at 
450 and 550 nm. Generation of standard 
curve was done by plotting the average ab-
sorbance (450 nm minus 550 nm) for each 
standard concentration on the vertical (Y) 
axis vs the corresponding TNF-α concentra-
tion on the horizontal (X) axis. 
Determination of TNF-: Estimation of 
TNF- was done as per Life Technologies 
instructions: In brief, empty wells were 
rinsed upto four times by diluted assay buff-
er. Each well was completely filled with as-
say buffer during each wash. The plate was 
inverted between washing to empty the fluid 
from the wells. After the last washing, gently 
tap the inverted plate on absorbent to remove 
assay buffer. Now, addition of 100 µl of 
CRP TMB substrate solution to each well 
was done. The plate was covered with plastic 
film and incubated for 15 minutes at RT in 
the dark. Optimum development was ob-
tained by using an orbital shaker equipped 
with a large, flat cover to allow the plate(s) 
to develop in the dark. Addition of 100 µl of 
CRP HRP stop solution to each well was 
done. Blue colour turned into yellow and 
colourless wells remained colourless; ab-
sorbance was taken at a wavelength of 
450 nm. 
Estimation of Rheumatoid arthritic fac-
tor: Rheumatoid factor (RF) estimation was 
done as per Life Technologies instructions. 
This assay employs the qualitative enzyme 
immunoassay technique. The microtiter plate 
provided in the kit was pre-coated with anti-
gen. Samples (50-100 µl) were pipetted into 
the wells with anti-human IgA conjugated 
horseradish peroxidase (HRP). Antibodies, 
specific for the present antigen was bound to 
the pre-coated antigen. Now, plates were 
washed to remove any unbound reagent, a 
substrate solution was added to the wells. 
Colour was developed in proportion to the 
amount of human RF antibody (IgA) bound 
in the initial step. The colour development 
was stopped and the intensity of the colour 
was measured. Detection wavelength: 
450 nm versus 620 nm within 30 min after 
adding the stop solution. Result was calcu-
lated by standard curve plot. 
Estimation of IL-6: IL-6 estimation was 
done as per Life Technologies instructions. 
In brief, 100 μL of the Standard Diluent 
Buffer was added to zero wells. Well(s) re-
served for chromogen blank was left empty. 
100 μL of standards, samples or controls 
were added to the appropriate microtiter 
wells. Pipetted 50 μL of biotinylated anti-IL-
6 (Biotin Conjugate) solution was pipetted 
into each well except the chromogen 
blank(s), incubated for 2 hours at RT. Wells 
were washed 4 times and addition of 100 μL 
Streptavidin-HRP working solution was add-
ed to each well except the chromogen 
blank(s), incubated for 30 minutes at RT and 
wells were again washed for 4 times. 100 μL 
of Stabilized Chromogen was then added to 
each well. The liquid in the wells turned to 
blue. Addition of 100 μL of Stop Solution to 
each well was done. The absorbance was 
measured at 450 nm. Estimation of IL-6 con-
centrations for unknown samples and con-
trols was done from the standard curve plot-
ted. 
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Detection of auto-antibodies against  
hydroxyl radical damaged collagen-II 
The presence of antibodies against OH-
collagen II in the sera of OA patients was 
evaluated by enzyme linked immune sorbent 
assays (Shahab et al., 2012b; Ahmad et al., 
2014a, 2011a). The blood samples were al-
lowed to clot and sera were separated. The 
serum samples from normal and healthy 
people served as control. Briefly, microtitre 
wells were coated with one hundred micro-
litre of OH-collagen II (10 g/ml in TBS, pH 
7.4) and incubated for 2 hours at 37°°C and 
overnight at 4 °C, respectively. Each sample 
was coated in duplicate and half of the plate, 
devoid of antigen, served as control. The 
test-plate wells were emptied and washed 
thrice with TBS-T to remove the unbound 
antigen. Unoccupied sites were blocked with 
150 l of 1.5 % non-fat dry milk in TBS (pH 
7.4) for 4-5 hours at 4 °C followed by single 
wash with TBS-T. In direct binding ELISA, 
antibodies were directly added into antigen-
coated wells and incubated for 2 hr at 37 °C 
and overnight at 4 °C, respectively. The 
wells were emptied and washed thoroughly 
with TBS-T. Anti-immunoglobulin G (Anti-
IgG) alkaline phosphatase conjugate was 
added to each well and incubated at 37 °C 
for 2 hours and then the plates were washed 
thrice with TBS-T followed by a single wash 
with distilled water. Para-nitrophenyl phos-
phate was added and the developed colour 
was read at 410 nm on a microplate reader. 
The results were expressed as mean differ-
ence of absorbance values in test and control 
wells (Atest – Acontrol). 
 
RESULTS 
Biochemical and physiological parame-
ters analyzed are given in Table 5. Among 
physiological parameters, Hb % did not 
change in male OA patients as compared to 
female subjects. The level of ESR was sig-
nificantly increased in both male and female 
subjects of OA patients. Other parameters 
like TLC was found to be significantly de-
creased (*P<0.001; females **P≤0.05; 
males). The change in ALC was found to be 
negligible, indicating the occurrence of in-
fection and inflammation in OA patients. 
In biochemical tests, uric acid (UA) level 
was higher in both male and female OA pa-
tients. In lipid profile, total cholesterol (TC) 
and low density lipoprotein cholesterol 
(LDL-C) were significantly increased 
(P<0.001), while HDL-C was significantly 
decreased in OA patients of female subjects 
only. Triglyceride (TG) remained constant in 
both sexes, suggesting no role in causing 
OA. Moreover, the serum estradiol level was 
significantly decreased in female OA pa-
tients. 
The immunological parameters estimated 
are given in Table 6. Among immunological 
parameters, the percentage of CRP, TNF- 
and IL-6 were significantly increased in male 
subjects (*P<0.001). This indicates induction 
of bone resorbing activity or tissue break-
down in OA patients. In female subjects 
CRP, TNF- and IL-6 were also increased 
significantly (*P<0.001) (Table 6), which 
suggests that decreasing level of estradiol 
could be a cause of OA in females.  
To analyze the role of OH-collagen II in 
eliciting immune response in OA patients, 
the presence of auto-antibodies in arthritis 
subjects against OH-collagen II was probed 
by direct binding ELISA (Shahab et al., 
2013; Ahmad et al., 2011b; Moinuddin et al., 
2014; Akhter et al., 2014a, b). Out of 100 
arthritic sera (50 male and female each), 30 
male patient samples (60 %) showed higher 
binding with the OH-collagen II as compared 
to the native form, however, 40 female sub-
jects (80 %) showed enhanced binding. 
These results point towards that most of the 
OA subjects (70 %) showed the presence of 
auto-antibodies against OH-collagen II sug-
gesting the role of hydroxyl radical damaged 
collagen II in the OA patients. Type II colla-
gen posttranslationally modified by OH. rad-
ical that are present in the inflamed joint is 
an autoantigen in OA patients. 
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Table 5: Status of physiological and biochemical parameters of male and female subjects of control and osteoarthritic groups 
 
Study  
Groups 
 
 
 
Male  
(Female) 
Control  
subjects  
(n=10 
each) 
 
 Hb
(gm%) 
♂- 
[13.5-16.0] 
♀- 
[12.0-15.0] 
ESR 
(mm/hour) 
♂- 
[1-20] 
♀- 
[1-30] 
TLC
(cu/mm) 
4000-11000 
 
 
Absolute 
lymphocyte 
count 
800-4800 
Serum
uric acid 
(mg/dl) 
♂-[3.5-8.0] 
♀-[2.5-5.8] 
TC 
(mmol/l) 
≤ 5.2 
 
TG
(mmol/l) 
≤ 1.7 
 
HDL-c
(mmol/l) 
♂-[>1.0] 
♀-[>1.3] 
LDL-c
(mmol/l) 
2.60 
Serum 
estrogen 
(pg/ml) 
♂-[NA] 
♀-[40.0] 
 
Mean 
± SD 
12.91.35 
(12.20.87) 
 
13.91.15 
(14.82.63) 
 
52961243 
(5439951) 
 
1854461 
(1820372) 
4.911.13 
(4.920.88) 
4.840.58 
(5.680.65) 
1.450.24 
(1.450.16) 
1.100.20 
(0.980.19) 
3.070.60 
(4.03 0.71)
----(37.119) 
SE 0.19  
(0.12) 
0.21  
(0.37) 
75.82  
(138.52) 
65.33  
(52.71) 
0.15 
(0.12) 
0.08 
(0.09) 
0.03 
(0.02) 
0.02 
(0.02) 
0.08 
(0.10) 
---- 
(2.82) 
 
Male  
(Female) 
Knee 
Osteo-
arthritic 
subjects 
(n=40 
each) 
Mean 
± SD 
12.50.94NS 
(9.780.83) 
32.424.4
(33.874.4)
465585 **
(4561439)
1891352NS
(1840306NS) 
8.820.85 
(8.730.82)
6.420.71
(6.150.78)
1.67 0.44NS
(1.680.40NS)
0.860.12NS
(0.860.14)
4.76 0.79
(4.530.79)
---- 
(26.915.18) 
 
SE 0.11 
(0.07) 
0.52 
(0.39) 
69.99 
(38.52) 
42.13 
(26.91) 
0.10 
(0.07) 
 
0.08 
(0.06) 
0.05 
(0.03) 
0.01 
(0.01) 
0.09 
(0.06) 
---- 
(1.33) 
Values expressed as Mean  SD,*P<0.001, **P ≤0.05, NS - Non significant; NA - Not applicable. 
Values in parenthesis denote female readings. 
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Table 6: Status of immunological parameters of male and female subjects of control and osteoarthritic 
groups 
 
 
 
Study group 
C-reactive protein 
[< 1.0 mg/L] 
Rheumatoid Arthrit-
ic factor 
[<15.0 IU/ml] 
 
TNF- 
(pg/mL) 
[0.0-6.0] 
 
IL-6 (pg/mL) 
[0.0-500] 
Positive 
% 
Negative 
% 
Positive 
% 
Negative 
% Mean ± SD Mean ± SD 
Control subjects, 
male 
(n=20) 
0 % 100 % 0 % 100 % 6.2  1.4 148  7.9 
Male Knee  
Osteoarthritic 
subjects 
(n=40) 
62.5 % 37.5 % 0 % 100 % 32.6  8.1 327  8.6
 
 
Control subjects, 
female 
(n=20) 
0 % 100 % 0 % 100 % 6.1  1.8 133  7.8 
Female Knee 
Osteoarthritis 
subjects 
(n=60) 
73.5 % 26.5 % 0 % 100 % 42.3  9.8 384  8.1 
Values expressed as Mean  SD, *P<0.001, **P ≤0.05, NS = Non significant. 
The cut off value is as per manufacturer’s instructions. 
 
 
DISCUSSION 
OA is a destruction of cartilage bone 
with the period of time and collagen type II 
is one of the most pronounced long lived 
proteins responsible for it (Shahab et al., 
2012a). Our results demonstrate that among 
all the parameters like physiological, bio-
chemical and immunological, the immuno-
logical parameters showed intense changes 
or significantly induced level of TNF-and 
IL-6 in both male and female patients suffer-
ing from OA. These swift in the levels of 
TNF-and IL-6 indicates its most probable 
role in OA. In female subjects this might be 
due to the decrease in the level of estradiol, 
which decreases post menopause. Moreover, 
for the early detection of OA, the auto-
antibodies (70 %) were found in the sera of 
patients against OH-collagen II. This points 
towards that there is the significant role of 
the hydroxyl radical in structural perturba-
tions of the collagen II making it immuno-
genic. 
Our research group is also working on 
some medicinal plants and its purified bioac-
tive compounds having highly antioxidant 
property likes Phullanthus virgatus (Hashim 
et al., 2013) and Boerhaavia diffusa (Akhter 
et al., 2013a). A research update on mecha-
nistic approaches of these plants has also 
been discussed. Eventually, based on these 
plants antioxidant characteristics it is hy-
pothesized that; the damage caused to the 
cartilage of OA patients can be recovered 
from bioactive compounds or plant extracts 
having potent anti-oxidant property. We 
have shown recently the antioxidant poten-
tial of some drugs and nanoparticles which 
might be used for the inhibitory activity of 
oxidative and glycative stress as well (Ah-
mad et al., 2013a, b, 2014b, c; Ashraf et al., 
2015a-c; Ahmad, 2014; Ahmad and Sid-
diqui, 2015). The anti-glycation and antioxi-
dant potential of glycation assisted gold 
nano-particles (Gnps) have been recently 
discussed in bone cancer cells (Rahim et al., 
2014). 
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CONCLUSION 
It is concluded that immunological pa-
rameters are better forecaster for the diagno-
sis of OA than biochemical and physiologi-
cal parameters. A defect of the immunologi-
cal parameters might be use as foremost fac-
tors and mechanisms of compensation. The 
incidence of adverse effects for herbal medi-
cines appears to be low and they may offer a 
much needed alternative for patients with 
OA. This study also opens an opportunity to 
study the effect of Gnps on arthritis as well. 
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